|
|
Article: Rethinking Pharmaceutical R&D: Will New Strategies Yield a Pipeline Payoff?
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Research and Markets (http://www.researchandmarkets.com/research/e2c21e/rethinking_pharmac) has announced the addition of Decision Resources, Inc.'s new report "Rethinking Pharmaceutical R&D: Will New Strategies Yield a Pipeline Payoff?" to their offering (see also Research and Markets).
Can radical changes to the structures and strategies of pharmaceutical R&D operations-such as creating more entrepreneurial environments modeled upon biotech companies-increase their productivity?
Many major companies are reorganizing the research branches of their businesses and finding creative ways to partner with biotech companies and with each other to access or ...